Archived listing. This role was posted over 30 days ago and is no longer accepting applications. We keep it for reference, but the employer may have already filled it. See today's verified listings.

Pharmacovigilance Expert

micro1 Remote

See live roles like this Save · sign in Alert me to jobs like this

This one is closed

Live roles like this one

See every "Pharmacovigilance Expert" role →

Posted 05 Aug 2026
Last seen 05 Aug 2026
Location Remote
Lifecycle aged
Grade F
This listing scored 34/100, which is an F. It lost the most ground on pay transparency. See the breakdown

-10 Ghost-job penalty — Deducted for signals that this posting may not be a real, currently-open role — staleness, repeated relisting, or talent-pool language.

Every figure above is arithmetic over the posting itself — its salary field, its text, its age, its tags and how many sources carry it. How the grades work →

Role Title: Pharmacovigilance Expert

Role Type: Contractor

Location: Remote

micro1 is engaging Pharmacovigilance Experts to contribute their advanced drug safety expertise on a key customer project. In this role, you'll apply your expertise to help train next-generation AI systems. Your work will shape how models learn, reason, and perform through high-quality, real-world input. No prior experience in AI is required — your domain knowledge is what matters. This opportunity is ideal for professionals experienced in authoring and reviewing complex safety reports, passionate about data quality, and committed to clear written and verbal communication.

Scope of Work

  1. Author and review evaluation tasks based on DSURs, PSURs/PBRERs, and associated safety data and case-level records.
  2. Apply expert judgment to assess the accuracy and adequacy of interval safety findings, signal evaluations, and benefit-risk conclusions in alignment with best practices.
  3. Assess template and structural conformity to ICH E2F and ICH E2C requirements, including proper section content, presentation of cumulative versus interval data, and completeness of appendices.
  4. Reconcile figures and case counts across report sections and data sources, identifying and documenting discrepancies significant for regulatory review.
  5. Evaluate safety conclusions in light of new data or events, and provide clear, structured written rationales supporting your determinations.
  6. Deliver structured feedback to inform the development of AI-driven tools for pharmacovigilance documentation and analysis.

Preferred Qualifications

  1. 5+ years of pharmacovigilance or drug safety experience at a sponsor, CRO, or as an independent consultant.
  2. Demonstrated proficiency in authoring or reviewing DSURs and/or PSURs/PBRERs from start to finish.
  3. Working fluency with ICH E2F, ICH E2C(R2), and GVP guidelines, including signal management and benefit-risk assessment methodology.
  4. Hands-on experience with MedDRA coding, seriousness and causality assessment, expectedness determination, and aggregate safety data analysis.
  5. Expertise in reconciling aggregate safety data and identifying inconsistencies with case-level information.
  6. Advanced degree in life sciences, pharmacy, nursing, or medicine (PharmD, MD, MSc, or equivalent).
  7. Experience in both development-stage and post-marketing safety reporting, QPPV or deputy QPPV roles, safety committee participation, or AI-assisted safety review tools is a plus.

Originally posted on Himalayas

Apply for this role Opens himalayas.app — the link as listed; we have not yet verified it is the employer's own page

Quick question · anonymous · one tap

Would you apply to this job?

Answer to see what other job seekers said.

Your turn · no account needed

Help the next applicant

You may know something about this listing that we cannot see from here. One tap. No account needed. Signed-in reports earn points once the evidence agrees with you.

I know what it pays

What you were offered, quoted in an interview, or paid in this role. A range is fine.

Sign in with Google to earn points for reports — 100 confirmed points buy a week of Early Access.

Where this listing came from

  1. 05 Aug 2026 Himalayas first sighting

Seen on 1 board over 0 days.